Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. VVCIF

VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

Comment by Schaffhausenon Oct 29, 2020 10:41am
179 Views
Post# 31802969

RE:Vivo hit bottom at .12sh....onwards & upwards from here

RE:Vivo hit bottom at .12sh....onwards & upwards from here
The only cockroach remaining is the auxly arbitration. I feel that if we get an arbitration settlement less than 3M it will be viewed as good news. 3 to 4.5M will be neutral and 4.5 to 8.8M will be bad news. I want this arbitration to conclude because we have no other skeletons left in the closet. VIVO is squeaky clean besides that and with revenue growth projections Q1 2021 will be excellent since streamlining, negligible interest costs and above all, no looming debentures. Just look at Aleafia, an excellent comparison to VIVO, but they have 65M in debentures with the first 25M coming due in Feb 2021, and they have an interest rate over 8% and bloated overheads that will make their profitability horizon further into the distance...their remaing 40M debentures come due in June 2022 so they will likely see the same short attack as we have already passed through. The clouds are parting for VIVO now. Cheers, Schaff
<< Previous
Bullboard Posts
Next >>